Insulet Corp. logo
PODDInsulet Corp.

Is the P/B ratio high or low?

The P/B ratio of 8.02 is 70% below its 5-year average of 26.53, near the low end of its 5-year range (7.46–50.77).

39.69% below its 12-month average of 13.30.

PODD PB Ratio

PODD PB Ratio Chart

8.02
-53.70% 1Y
PODD PB Ratio

PODD Average PB Ratio Chart

PODD PB Ratio

PODD Current vs Average PB Ratio Chart

PODD PB Ratio Metrics

PB RATIO

8.02

PB RATIO AVG TTM

13.30

PB RATIO AVG 3Y

16.65

PB RATIO AVG 5Y

26.53

PB RATIO AVG 10Y

31.34

PB RATIO AVG 15Y

27.54

PB RATIO AVG 20Y

24.27

CURRENT VS TTM AVG

-39.69%

CURRENT VS 3Y AVG

-51.84%

CURRENT VS 5Y AVG

-69.77%

CURRENT VS 10Y AVG

-74.41%

CURRENT VS 15Y AVG

-70.88%

CURRENT VS 20Y AVG

-66.96%

PODD Competitors' PB Ratio

NAMEMARKET CAPPB RATIOTTM3Y5Y
Insulet Corp. (PODD)$10.31B8.0213.3016.6526.53
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B1.441.000.991.29
Baxter International Inc. (BAX)vs ›$10.87B1.791.582.223.02
Charles River Laboratories International, Inc. (CRL)vs ›$9.73B3.362.662.833.98
Henry Schein, Inc. (HSIC)vs ›$9.55B2.942.642.642.84
Revvity, Inc. (RVTY)vs ›$11.78B1.651.501.652.12
Align Technology, Inc. (ALGN)vs ›$12.24B2.952.964.366.23
Bio-Rad Laboratories, Inc. (BIO)vs ›$7.57B1.101.121.141.29
Oscar Health, Inc. (OSCR)vs ›$7.56B5.784.163.692.76
Solventum Corporation (SOLV)vs ›$13.09B2.673.013.373.37

P/B vs. its own history

At 8.02, P/B is cheaper than usual, sitting higher than 9% of its 19-year history.

19-year low

1.75

median

23.84

19-year high

1443.88

cheaperricher

Book Value Analysis

P/B Ratio

8.02

Market Price / Book Value per Share

PB Ratio Formula & Definition

PB Ratio = Market Cap / Total Shareholders' Equity

The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Insulet Corp. (PODD)?
The P/B ratio for PODD stock is 8.02.
Is Insulet Corp.'s P/B ratio high or low?
The P/B ratio of 8.02 is 70% below its 5-year average of 26.53, near the low end of its 5-year range (7.46–50.77).
What is the TTM average P/B ratio for Insulet Corp. (PODD)?
The TTM average P/B ratio for PODD stock is 13.30.
What is the 3Y average P/B ratio for Insulet Corp. (PODD)?
The 3Y average P/B ratio for PODD stock is 16.65.
What is the 5Y average P/B ratio for Insulet Corp. (PODD)?
The 5Y average P/B ratio for PODD stock is 26.53.
What is the 10Y average P/B ratio for Insulet Corp. (PODD)?
The 10Y average P/B ratio for PODD stock is 31.34.
What is the 15Y average P/B ratio for Insulet Corp. (PODD)?
The 15Y average P/B ratio for PODD stock is 27.54.
What is the 20Y average P/B ratio for Insulet Corp. (PODD)?
The 20Y average P/B ratio for PODD stock is 24.27.

PODD PB Ratio History

DATEPB RATIO
2026-06-248.02
2026-06-237.76
2026-06-227.49
2026-06-187.86
2026-06-177.73
2026-06-167.96
2026-06-157.98
2026-06-128.07
2026-06-118.04
2026-06-108.12
2026-06-098.60
2026-06-088.17
2026-06-058.26
2026-06-047.89
2026-06-037.72
2026-06-027.68
2026-06-017.98
2026-05-297.81
2026-05-287.69
2026-05-277.87
2026-05-268.29
2026-05-228.35
2026-05-218.46
2026-05-208.44
2026-05-198.33
2026-05-188.22
2026-05-157.95
2026-05-148.01
2026-05-138.02
2026-05-128.53
2026-05-118.31
2026-05-088.31
2026-05-078.64
2026-05-068.15
2026-05-057.81
2026-05-047.99
2026-05-018.16
2026-04-308.03
2026-04-297.46
2026-04-288.53
2026-04-278.78
2026-04-248.84
2026-04-238.96
2026-04-229.03
2026-04-218.97
2026-04-209.37
2026-04-179.50
2026-04-169.40
2026-04-159.44
2026-04-149.40
2026-04-139.23
2026-04-109.18
2026-04-099.30
2026-04-089.49
2026-04-079.44
2026-04-069.49
2026-04-029.53
2026-04-019.66
2026-03-319.79
2026-03-309.70
2026-03-279.71
2026-03-2610.17
2026-03-2510.07
2026-03-2410.52
2026-03-2310.59
2026-03-2010.59
2026-03-1910.66
2026-03-1810.74
2026-03-1710.75
2026-03-1610.48
2026-03-1310.25
2026-03-1211.01
2026-03-1111.14
2026-03-1011.11
2026-03-0911.21
2026-03-0611.05
2026-03-0511.24
2026-03-0411.33
2026-03-0311.28
2026-03-0211.45
2026-02-2711.50
2026-02-2611.73
2026-02-2511.57
2026-02-2411.44
2026-02-2311.63
2026-02-2011.28
2026-02-1911.62
2026-02-1812.04
2026-02-1712.58
2026-02-1312.39
2026-02-1212.29
2026-02-1112.81
2026-02-1012.89
2026-02-0912.54
2026-02-0612.35
2026-02-0512.41
2026-02-0412.83
2026-02-0312.83
2026-02-0213.10
2026-01-3013.06
2026-01-2913.02
2026-01-2813.18
2026-01-2713.52
2026-01-2613.85
2026-01-2313.87
2026-01-2214.29
2026-01-2114.55
2026-01-2014.51
2026-01-1614.69
2026-01-1514.63
2026-01-1414.44
2026-01-1314.20
2026-01-1214.22
2026-01-0914.76
2026-01-0814.95
2026-01-0715.27
2026-01-0615.03
2026-01-0514.47
2026-01-0214.44
2025-12-3114.51
2025-12-3014.65
2025-12-2914.67
2025-12-2614.74
2025-12-2414.74
2025-12-2314.58
2025-12-2214.89
2025-12-1914.79
2025-12-1814.95
2025-12-1714.78
2025-12-1614.74
2025-12-1514.88
2025-12-1215.10
2025-12-1115.02
2025-12-1015.07
2025-12-0915.02
2025-12-0815.12
2025-12-0515.54
2025-12-0416.13
2025-12-0315.70
2025-12-0215.78
2025-12-0115.87
2025-11-2816.70
2025-11-2616.68
2025-11-2516.79
2025-11-2417.23
2025-11-2116.91
2025-11-2015.97
2025-11-1917.68
2025-11-1817.02
2025-11-1716.75
2025-11-1416.98
2025-11-1316.98
2025-11-1217.20
2025-11-1116.66
2025-11-1016.35
2025-11-0716.33
2025-11-0616.51
2025-11-0515.18
2025-11-0415.47
2025-11-0315.39
2025-10-3115.11
2025-10-3015.06
2025-10-2915.27
2025-10-2815.66
2025-10-2715.73
2025-10-2415.50
2025-10-2315.62
2025-10-2215.90
2025-10-2115.89
2025-10-2015.78
2025-10-1715.38
2025-10-1615.27
2025-10-1515.09
2025-10-1415.37
2025-10-1315.19
2025-10-1015.19
2025-10-0915.47
2025-10-0815.23
2025-10-0715.14
2025-10-0615.05
2025-10-0314.93
2025-10-0215.08
2025-10-0114.78
2025-09-3014.91
2025-09-2915.00
2025-09-2615.36
2025-09-2515.63
2025-09-2415.79
2025-09-2315.83
2025-09-2216.18
2025-09-1915.98
2025-09-1816.10
2025-09-1715.56
2025-09-1616.04
2025-09-1516.43
2025-09-1216.50
2025-09-1116.32
2025-09-1016.30
2025-09-0917.04
2025-09-0816.88
2025-09-0516.83
2025-09-0416.73
2025-09-0316.59
2025-09-0216.66
2025-08-2916.41
2025-08-2816.30
2025-08-2716.15
2025-08-2616.02
2025-08-2515.89
2025-08-2215.97
2025-08-2115.83
2025-08-2016.08
2025-08-1915.81
2025-08-1815.60
2025-08-1515.51
2025-08-1415.25
2025-08-1314.91
2025-08-1214.95
2025-08-1114.72
2025-08-0814.83
2025-08-0714.66
2025-08-0615.44
2025-08-0515.65
2025-08-0416.03
2025-08-0115.87
2025-07-3116.06
2025-07-3016.61
2025-07-2916.23
2025-07-2816.28
2025-07-2516.16
2025-07-2415.96
2025-07-2315.97
2025-07-2215.90
2025-07-2115.65
2025-07-1815.83
2025-07-1715.79
2025-07-1616.05
2025-07-1516.15
2025-07-1416.26
2025-07-1116.11
2025-07-1016.56
2025-07-0916.57
2025-07-0816.51
2025-07-0716.75
2025-07-0316.77
2025-07-0216.80
2025-07-0116.71
2025-06-3017.50
2025-06-2717.44
2025-06-2617.26
2025-06-2517.05
2025-06-2417.32
2025-06-2317.14
2025-06-2016.88
2025-06-1816.81
2025-06-1716.95
2025-06-1617.07
2025-06-1316.97
2025-06-1216.91
2025-06-1116.83

Showing the most recent 260 of 4,688 data points. The chart above shows the full history.

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA
5,400 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ashley A. McEvoy